Markets:

Overview

News

Currencies

International

Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

1,052.89 +14.78 (+1.42%)

Streaming Delayed Price Updated: 11:26 AM EDT, Aug 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about argenx SE - American Depositary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

What 8 Analyst Ratings Have To Say About argenx ↗

January 18, 2022

Analysts have provided the following ratings for argenx (NASDAQ:ARGX) withi...

Via Benzinga

argenx Highlights Strategic Priorities for 2022

January 07, 2022

From argenx

Via Business Wire

What 8 Analyst Ratings Have To Say About argenx ↗

December 21, 2021

Within the last quarter, argenx (NASDAQ:ARGX) has observed the following an...

Via Benzinga

38 Stocks Moving In Monday's Mid-Day Session ↗

December 20, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE: CANF...

Via Benzinga

Analyst Ratings For argenx ↗

December 08, 2021

Analysts have provided the following ratings for argenx (NASDAQ:ARGX) withi...

Via Benzinga

Analyst Ratings For argenx ↗

October 19, 2021

Analysts have provided the following ratings for argenx (NASDAQ:ARGX) with...

Via Benzinga

Expert Ratings For argenx ↗

October 07, 2021

Analysts have provided the following ratings for argenx (NASDAQ:ARGX) with...

Via Benzinga

65 Biggest Movers From Yesterday ↗

December 21, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock...

Via Benzinga

Argenx's Vyvgart Wins FDA Approval For Autoimmune, Neuromuscular Disease ↗

December 20, 2021

The FDA has approved Argenx SE's (NASDAQ: ARGX) Vyvgart (efgartigimod alfa-fcab) for generalized myasthenia gravis (gMG) in adult patients who are anti-...

Via Benzinga

A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 4% ↗

December 20, 2021

Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session. The Federal Reserve, last week...

Via Benzinga

5 Stocks To Watch For December 20, 2021 ↗

December 20, 2021

Some of the stocks that may grab investor focus today are: Wall Street expects Carnival Corporation (NYSE: CCL) to report a quarterly loss at $1.27 per share on revenue of $1....

Via Benzinga

The Week Ahead In Biotech (Dec. 19-25): Key Events Of Holiday-Shortened Week ↗

December 19, 2021

Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also drew strength from some...

Via Talk Markets

The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week ↗

December 19, 2021

Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also...

Via Benzinga

argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis

December 17, 2021

From argenx SE

Via Business Wire

The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx ↗

December 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral...

Via Benzinga

2 Mid-Cap Biopharma Stocks BofA Securities Recommends For 2022 ↗

December 14, 2021

Biotech stocks are risky investments and to make a profit informed decision-making is needed. BofA Securities announced its ...

Via Benzinga

The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More ↗

December 12, 2021

Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound. Multiple...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 ↗

December 08, 2021

Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates ↗

December 02, 2021

A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for...

Via Benzinga

What 4 Analyst Ratings Have To Say About argenx ↗

November 29, 2021

Over the past 3 months, 4 analysts have published their opinion on argenx (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021 ↗

November 29, 2021

Upgrades According to Odeon Capital, the prior rating for Wells Fargo & Co (NYSE:

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

November 29, 2021

Citigroup cut Merck & Co., Inc. (NYSE: MRK) price target from $105 to $85. Merck shares fell 2% to $77.55 in pre-market trading. Keybanc lowered Arista Networks, Inc. (...

Via Benzinga

Death Cross Looms Over argenx Investors ↗

November 17, 2021

If history is any guide, there may be trouble ahead for shares of argenx (NASDAQ:ARGX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021 ↗

October 29, 2021

Upgrades For Preferred Bank (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 29, 2021

Gainers OptiNose (NASDAQ:OPTN) stock rose 17.74% to $3.11 during Friday's pre-market session. The company's market cap stands at $165.7 million. DBV Technologies (...

Via Benzinga

A Peek Into The Markets: US Stock Futures Down; Apple Posts Downbeat Sales ↗

October 29, 2021

Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones jumped more than 200 points in the previous session. Investors are awaiting earnings...

Via Benzinga

Topics Stocks

argenx SE (ARGX) Q3 2021 Earnings Call Transcript ↗

October 28, 2021

ARGX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021 ↗

October 19, 2021

Upgrades Maxim Group upgraded the previous rating for Indaptus Therapeutics Inc (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021 ↗

October 07, 2021

Upgrades For State Street Corporation (NYSE:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021 ↗

September 23, 2021

Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.